Ventria Bioscience faced controversy for producing plant-made pharmaceuticals. Stakeholders like environmentalists and farmers opposed Ventria's work due to concerns about contaminating crops and unknown health risks. Ventria's CEO Scott Deeter worked to address these concerns through transparency, addressing risks, and political action. However, their efforts were unsuccessful and expansion was blocked. Ventria now has few options and unhappy investors as it has been unable to expand since starting.

1. Ventria Bioscience
Case #4 Ventria Bioscience and the Controversy over Plant–Made Medicines Sinforosa Business
and Society – BUS 475 Professor Filomena May 17, 2011 1.–Describe the problem facing Scott
Deeter and Ventria. Deeter came to Ventria in April 2002. He was appointed as Ventria's CEO
because of his good reputation as a businessman. As CEO he helped Dr. Raymond Rodriguez sort
through several projects that Ventria was working on at the time. His concept of the business was to
focus on one or two projects to make Ventria a profitable business. 2.–Describe the relevant
stakeholders and for each, state its interests and sources of power. Rice farmers, are more than 2000
businesses owned by families and ... Show more content on Helpwriting.net ...
5.–Describe what other options Ventria has if it chooses not to engage in dialogue or political action
(or dialogue and political action are unsuccessful). Ventria's political action didn't work because the
secretary of Agriculture ruled in favor of the farmers, millers and the public. Ventria choose to
address the stakeholder's concerns. At this point, Deeter, Ventria's CEO, decided to use protective
equipment for field production, storage, and transportation. They will allow visits to their research
facilities and will keep detailed records of the research. All efforts by Ventria were not satisfactory
to the stakeholders and the efforts to expand where unsuccessful. In biotechnology, things always
seemed to take longer (Lawrence and Weber, 2011). Ventria has a long way to go and investors are
not happy. They have not been able to expand since the company started. References Pamer, M.
(2004, July). Prescription Rice Message posted to http://ecologycenter.org/terrain/issues/summer–
2004/prescription–rice/ California Rice Commission statical Report, May 1, 2005 Lawrence, A. T.
(2008). Business and Society. In B. Gordon (Ed.), Ventria Bioscience and the Controversy over
Plant–Made Medicines (Vol. Thirteenth Edition, p. 500). New York, NY: MMcGraw–Hill Irwin.
... Get more on HelpWriting.net ...

3. Scott Deeter And Ventri Ethical Dilemmas
Scott Deeter and Ventria faced many problems over the controversy over plant–made medicines.
There are many regulations that control farmed pharmaceuticals. There is the FDA, GRAS, EPA,
and the USDA that all have requirements that companies such as Ventria must abide by. In addition
to the list of regulations that must be followed, companies must also indirectly make sure the local
rice industry approved of the new techniques. People fear things that they don't understand. They
feared the crops would cross contaminate and pollute the state. They weren't sure of all of the risks,
involved in their industry. According to the text, in the early 2,000's the FDA basically created
standard that was directed toward pharmaceutical crops and food crops ... Show more content on
Helpwriting.net ...
Of course, it is ideal to want to grow it in natural soil, however, the risk of it polluting the
environment, diseases forming and spreading plus the unknown dangers to the affects on the
community. The stakeholders cannot ignore, the unknown answers to the questions that people have.
Agricultural companies in areas that don't have the best climate, or where the environment isn't
suitable for growth, use innovative habitats such as greenhouses. If I were a Ventria stakeholder, I
would suggest using indoor agricultural methods to grow the products in, so the environment and
the public's health would not be at risk. 4. If Ventria chooses to employ a political action strategy,
how might it go about influencing relevant regulators? Relevant regulators only want answers to the
their unknown questions. Their purpose is to make sure what is being done, is done with tact, and
concern for the majority of the people. Ventria needs to find answers, develop a safe proposal that
would make the government support and believe in their invention. Once they develop the positive
relationship with regulators, their objective should be to focus on the benefits of the product. If a
simple product, that isn't potentially harming the environment; can save lives, regulators may be
influenced to support the product. 5. If Ventria chooses not to engage in dialogue or political action
(or
... Get more on HelpWriting.net ...

5. Case Study: Ventria Bioscience
Date: April 24th, 2017
To: Environmentalists, Regulators, and Future Stakeholders
From: Johnny Spadafore, Student at GMU
Subject: Ventria Bioscience, improving productivity of rice, a crop recognized for its medically
useful proteins, providing benefits to human nutrition worldwide.
Ventria Bioscience Overview
Ventria Bioscience was founded by molecular biologist Dr. Raymond Rodriguez officially in 1993.
Professor Rodriguez began research and experiments in the 1980's in Sacramento, California with
some of his research colleagues and students. He began to develop techniques to extract, enhance
and purify rice by adding proteins (Recombinant DNA technology) and Dr. Rodriguez was later
funded with a large investment from Dr. William Rutter. ... Show more content on Helpwriting.net ...
Ventria has a huge opportunity to create relationships to farmers and consumers in the next years
and to contribute to communities around their farms and especially the government. Ventria should
continue to consider and experiment with different ideas and ways that will not only be approved by
the FDA, but can portray the benefits to environmentalists, food safety activists, consumer
advocates. The company regulations, goals and values allow them to ensure this by following all
rules and regulations and addressing and acknowledging any potential problem in their attempt to
achieve their bioscience organization goals. Scott Deeter does a phenomenal job of this by speaking
for the less fortunate and his passion for his company. Ventria will achieve their long terms company
goals by working closely with all government agencies concerned, especially California Rice
Commission. They will continue to seek stakeholder's investments, continue research studies and
stress to the public and the actual benefits of their rice product through testing. Stakeholders,
Investors, Board members, Government (includes FDA, APHIS, USDA), CRC (CA Rice
Commission), Scientists, and Environmentalists are all groups that have a stake in Ventria's actions.
All have interests and power regarding the plant made medicines and Ventria's decisions. A political
argument might be that government would have the most power, however APHIS has yet to approve
... Get more on HelpWriting.net ...

7. Ventria Bioscience Case Essay
Ventria Bioscience and the Controversy over Plant–Made Medicines
In this paper I am writing on the Ventria Bioscience and the Controversy over Plant–Made
Medicines Case. Ventria Bioscience is a company that is trying to commercialize pharmaceuticals
made from genetically modified plants. While Ventria is gaining opposition from regulators, activist,
and environmentalist; they could succeed if they use their relevant stakeholders and specific
strategies, information, financial incentive, constituency building, to influence regulators.
There are many groups that have a stake in Ventria's action. There are some stakeholders that hold a
lower salience such as, the environmentalist, consumer advocates, and food–safety activist. Which
are, ... Show more content on Helpwriting.net ...
These stakeholders are standing in the way of Ventria's attempt to solve malnutrition. For the market
stakeholders it begins with Scott Deeter, president and CEO of Ventria Bioscience, he built the
company, analyzing proteins and coming up with ideas. Then you have Dr. Raymond Rodriguez, he
is a molecular biologist that founded Ventria Bioscience. He approached Dr. William Rutter, founder
and chairmen of the biotechnology firm Chiron, to become an investor in the company. As the
company progressed, Dr. Rodriguez built a board of directors of biotech leaders and seasoned
entrepreneurs. This included Dr. William Rutter and Dr. Pablo Venezuela. William H. Rutter, an
attorney and venture capitalist. Ron Vogal, and bio–entrepreneur Dr. Robert Crea. Later recruited to
the board were Thomas N. Urban, Melvin Booth, and David Dwayer. Together these board members
and their organizations provide 85 percent of financing for the company. If these relevant
stakeholders were to have a dialogue, many opinions on how to reestablish the company's protocol
would be said. Specifically, strategies how to get pass the regulation issues and gain the approval of
different advocates. They will need to figure out a way to address their potential risk. Environmental
and consumer groups feel as though Ventria will contaminate other rice crops. If GM crops were to
contaminate other crops, California will be at risk of losing Japanese
... Get more on HelpWriting.net ...

9. Syllabus
Office Hours – BUS 344 TUES/THURS: 10am – Noon Office Hours – BUS 344 TUES/THURS:
10am – Noon Denise Kleinrichert, Ph.D. San Francisco State University email: dk@sfsu.edu
Seminar – Business & Society (BUS 682) Fall 2013 – Tuesdays Course Objectives: This course
emphasizes the theories and practices of the ethical, social, environmental, political, and legal
aspects of business decision–making and leadership practices. These areas reflect the mutual
impacts of profit, non–profit and government organizations in the U.S. and globally on business
stakeholders. Course activities will hone your critical analysis and interpersonal verbal, ... Show
more content on Helpwriting.net ...
Rules of the Game (think of each class as a Business Meeting): * Check your @sfsu.edu email
account and iLearn daily for any announcements, changes, or handouts. * Attendance and level of
Participation noted every class meeting: * Absences: will not be excused, except in extreme
situations (i.e., funeral for immediate family member, your hospitalization, jury duty, major religious
observance) with advance email notice to me. Plus, written documentation (obituary notice/funeral
home notice, hospital discharge, jury summons, etc.) is required for any excused absence and it must
be submitted at the next class meeting; otherwise, the absence is not excused and your
attendance/participation points for that class will be 0 pts. Your work schedule does not count as an
excused absence. Family or personal trips are not excused absences. Sick hamsters, bad hair days,
other classes' project deadlines, usual life stuff, etc. don't qualify! If in doubt about a needed
absence, talk to me or drop me an advance email. * If you miss a class, it is your responsibility to
obtain notes from a classmate (use iLearn email). * I do not email or post Power Point slides of my
class discussion notes. * Participation: the level of your active participation in all class discussions
and group / partnership exercises throughout each class meeting. Expectations: Professional conduct
for a business meeting. *Nonparticipation = leaving
... Get more on HelpWriting.net ...